Gladstone Institutional Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Buy |
5,990
+431
| +8% | +$175K | 0.1% | 213 |
|
|
2025
Q1 | $2.77M | Sell |
5,559
-9
| -0.2% | -$4.48K | 0.13% | 175 |
|
|
2024
Q4 | $2.9M | Sell |
5,568
-318
| -5% | -$165K | 0.13% | 170 |
|
|
2024
Q3 | $3.64M | Sell |
5,886
-748
| -11% | -$463K | 0.18% | 142 |
|
|
2024
Q2 | $3.67M | Buy |
6,634
+46
| +0.7% | +$25.4K | 0.19% | 143 |
|
|
2024
Q1 | $3.83M | Sell |
6,588
-1,577
| -19% | -$917K | 0.21% | 131 |
|
|
2023
Q4 | $4.33M | Buy |
8,165
+535
| +7% | +$284K | 0.24% | 110 |
|
|
2023
Q3 | $3.86M | Buy |
7,630
+1,827
| +31% | +$925K | 0.25% | 103 |
|
|
2023
Q2 | $3.03M | Sell |
5,803
-746
| -11% | -$389K | 0.18% | 142 |
|
|
2023
Q1 | $3.77M | Sell |
6,549
-494
| -7% | -$285K | 0.24% | 123 |
|
|
2022
Q4 | $3.88M | Buy |
7,043
+1,171
| +20% | +$645K | 0.27% | 105 |
|
|
2022
Q3 | $2.98M | Buy |
5,872
+3,189
| +119% | +$1.62M | 0.23% | 106 |
|
|
2022
Q2 | $1.46M | Sell |
2,683
-1,284
| -32% | -$698K | 0.12% | 204 |
|
|
2022
Q1 | $2.34M | Sell |
3,967
-4,884
| -55% | -$2.88M | 0.16% | 166 |
|
|
2021
Q4 | $5.91M | Buy |
8,851
+3,084
| +53% | +$2.06M | 0.46% | 57 |
|
|
2021
Q3 | $3.3M | Buy |
5,767
+3,909
| +210% | +$2.23M | 0.32% | 82 |
|
|
2021
Q2 | $937K | Buy |
1,858
+955
| +106% | +$482K | 0.11% | 200 |
|
|
2021
Q1 | $412K | Buy |
903
+272
| +43% | +$124K | 0.06% | 263 |
|
|
2020
Q4 | $294K | Buy |
+631
| New | +$294K | 0.06% | 230 |
|